Clinical Trial: SWOG S2212

SWOG S2212

Status: Open

Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

Eligible for screening study DCP 001